Table A2.
High Grade | Establishment Rate Among High Grade | Time to Establishment (days) | |||||
---|---|---|---|---|---|---|---|
No. | No. | % High Grade | No. | % (success/high grade) | Median | Range | |
Angiomyoplipoma | 1 | 0 | 0.0 | ||||
Angiosarcoma | 1 | 1 | 100.0 | 0 | 0.0 | ||
Chondrosarcoma | 1 | 0 | 0.0 | ||||
Chordoma | 1 | 0 | 0.0 | ||||
Dermatofibrosarcoma protuberans | 1 | 1 | 100.0 | 0 | 0.0 | ||
Desmoid tumor | 1 | 0 | 0.0 | ||||
Desmoplastic small round cell tumor | 2 | 100.0 | 0 | 0.0 | |||
Embryonal sarcoma | 1 | 1 | 100.0 | 0 | 0.0 | ||
Epithelioid sarcoma | 3 | 3 | 100.0 | 0 | 0.0 | ||
Ewing sarcoma, extraosseous | 3 | 3 | 100.0 | 1 | 33.3 | 49 | 49 |
Fibromyxoid sarcoma | 2 | 1 | 50.0 | 0 | 0.0 | ||
Follicular dendritic cell sarcoma | 2 | 2 | 100.0 | 1 | 50.0 | 23 | 23 |
GI stromal tumor | 7 | 4 | 57.1 | 1 | 25.0 | 84 | 84 |
Intramuscular angioma | 1 | 0 | 0.0 | ||||
Leiomyoma | 3 | 0 | 0.0 | ||||
Leiomyosarcoma | 15 | 15 | 100.0 | 8 | 53.3 | 86 | 29–170 |
Liposarcoma | 27 | 12 | 44.4 | 8 | 66.7 | 80 | 9–184 |
Malignant peripheral nerve sheath tumor | 1 | 0 | 0.0 | ||||
Myxofibrosarcoma | 5 | 5 | 100.0 | 3 | 60.0 | 70 | 14–121 |
Myxoma | 3 | 0 | 0.0 | ||||
NOS/spindle cell/UPS | 16 | 15 | 93.8 | 7 | 46.7 | 30 | 16–142 |
Osteosarcoma, extraosseous | 1 | 1 | 100.0 | 1 | 100.0 | 27 | 27 |
Phyllodes tumor | 1 | 1 | 100.0 | 0 | 0.0 | ||
Radiation-associated sarcoma | 1 | 1 | 100.0 | 0 | 0.0 | ||
Rhabdomyosarcoma | 1 | 1 | 100.0 | 1 | 100.0 | 44 | 44 |
Schwannoma | 1 | 0 | 0.0 | ||||
Solitary fibrous tumor | 3 | 0 | 0.0 | ||||
Synovial sarcoma | 2 | 2 | 100.0 | 1 | 50.0 | 91 | 91 |
Abbreviations: NOS, not otherwise specified; UPS, undifferentiated pleomorphic sarcoma.